Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma
- PMID: 27267910
- DOI: 10.1158/0008-5472.CAN-15-3385
Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma
Abstract
Fibroblast growth factor receptor 3 (FGFR3) plays important roles in cell proliferation, differentiation, and angiogenesis. FGFR3 is abnormally upregulated in hepatocellular carcinoma (HCC), where it correlates positively with clinicopathologic index, HCC differentiation, and advanced nuclear grade. In this study, we describe an aberrantly spliced transcript of FGFR3, termed FGFR3Δ7-9, was identified as a high frequency even in HCC. FGFR3Δ7-9 lacks exons encoding the immunoglobulin-like III domain and promoted the proliferation, migration, and metastasis of HCC cells both in vitro and in vivo Coimmunoprecipation and surface plasmon resonance assays demonstrated that the binding affinity of the aberrant FGFR3Δ7-9 receptor to FGFs was significantly higher than wild-type FGFR3IIIc Furthermore, FGFR3Δ7-9 could be self-activated by homodimerization and autophosphorylation even in the absence of ligand. Finally, FGFR3Δ7-9 more potently induced phosphorylation of the ERK and AKT kinases, leading to abnormal downstream signaling through the ERK and PI3K/AKT/mTOR pathways. FGFR3Δ7-9 also upregulated the metastasis-associated molecules Snail, MMP-9, and downregulated E-cadherin, which associated directly with FGFR3Δ7-9 Thus, as a ligand-dependent or -independent receptor, FGFR3Δ7-9 exerted multiple potent oncogenic functions in HCC cells, including proliferation, migration, and lung metastatic capacity. Overall, FGFR3 mRNA missplicing in HCC contributes significantly to its malignant character, with implications for therapeutic targeting. Cancer Res; 76(14); 4205-15. ©2016 AACR.
©2016 American Association for Cancer Research.
Similar articles
-
FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation.Med Oncol. 2016 May;33(5):46. doi: 10.1007/s12032-016-0761-9. Epub 2016 Apr 4. Med Oncol. 2016. PMID: 27044356
-
FGFR3△7-9 promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma.Cell Death Dis. 2020 Oct 23;11(10):903. doi: 10.1038/s41419-020-03089-2. Cell Death Dis. 2020. PMID: 33097695 Free PMC article.
-
Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.Oncotarget. 2015 Apr 10;6(10):7899-917. doi: 10.18632/oncotarget.3219. Oncotarget. 2015. PMID: 25760077 Free PMC article.
-
Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.J Hepatol. 2013 Oct;59(4):830-41. doi: 10.1016/j.jhep.2013.04.031. Epub 2013 May 7. J Hepatol. 2013. PMID: 23665184 Review.
-
[EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].Pathologe. 2014 Nov;35 Suppl 2:177-84. doi: 10.1007/s00292-014-2007-y. Pathologe. 2014. PMID: 25394965 Review. German.
Cited by
-
Signaling pathways in liver cancer: pathogenesis and targeted therapy.Mol Biomed. 2024 May 31;5(1):20. doi: 10.1186/s43556-024-00184-0. Mol Biomed. 2024. PMID: 38816668 Free PMC article. Review.
-
Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes.Int J Mol Sci. 2023 May 11;24(10):8597. doi: 10.3390/ijms24108597. Int J Mol Sci. 2023. PMID: 37239939 Free PMC article.
-
Impact of Alternative Splicing Variants on Liver Cancer Biology.Cancers (Basel). 2021 Dec 21;14(1):18. doi: 10.3390/cancers14010018. Cancers (Basel). 2021. PMID: 35008179 Free PMC article. Review.
-
Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets.Front Pharmacol. 2021 Apr 15;12:650388. doi: 10.3389/fphar.2021.650388. eCollection 2021. Front Pharmacol. 2021. PMID: 33935756 Free PMC article. Review.
-
FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention.Cancers (Basel). 2021 Mar 17;13(6):1360. doi: 10.3390/cancers13061360. Cancers (Basel). 2021. PMID: 33802841 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous